Full text is available at the source.
Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases
Interleukin-17A as a Possible Treatment Target in Long-Term Lung Diseases
AI simplified
Abstract
Interleukin-17A (IL-17A) is identified as a significant factor in various chronic respiratory diseases.
- IL-17A is involved in immune responses related to allergy and inflammation.
- The cytokine is linked to the progression of conditions such as Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia, and lung cancer.
- Increased levels of IL-17A may contribute to the severity of these respiratory diseases.
- Conversely, the absence of IL-17A could lead to a reduction in disease severity.
- The review highlights IL-17A as a potential target for therapeutic intervention in chronic respiratory conditions.
AI simplified